Back to Startups

Tcelltech

Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
About Tcelltech

Tcelltech is a clinical-stage biopharma focused on developing immunotherapies.

Business Information
Target Customers
healthcare providers research institutions pharmaceutical companies
Industry Categories
Bioscience & Disease Healthcare Systems
Business Model
Revenue Model Licensing and partnerships
Sales Channels direct sales, partnerships with healthcare organizations
Funding Timeline
Round Date Amount Investors
Series B Jul 15, 2025 $40.0M SDIC Fund
Founders
G
Gangxiong Huang

Founder & CEO

L
Lieping Chen

Co-Founder & CEO

Investors
S
SDIC Fund

Venture Capital

Recent Mentions
chuminhua432
Minhua Chu @chuminhua432
Jul 15, 2025

🇨🇳 Tcelltech announced the completion of a nearly $40 million Series B financing round. This round was led by SDIC Fund. Located in Boston and 🇨🇳 Fuzhou and founded by immunologist Lieping Chen and Gangxiong Huang, Tcelltech is a clinical-stage biopharma focused on developing

View on Twitter
Similar Startups
Health tech
89% match

Health Tech is an innovative startup focused on leveraging technology to improve healthcare delivery...
BioTroy Therapeutics
89% match

BioTroy Therapeutics is a biotechnology company focused on developing innovative anti-tumor therapeu...
Alaunos Therapeutics, Inc.
89% match

Alaunos Therapeutics, Inc. is a biotechnology company focused on developing innovative cell therapie...
Illimis Therapeutics
88% match

Illimis Therapeutics is a biotechnology company focused on developing innovative therapies to addres...